References
- Price B, Ware A. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005. Crit Rev Toxicol 2009;39:576-88. https://doi.org/10.1080/10408440903044928
- Tsao AS, Wistuba I, Roth JA, Kindler HL. Malignant pleural mesothelioma. J Clin Oncol 2009;27:2081-90. https://doi.org/10.1200/JCO.2008.19.8523
- Kim HR, Ahn YS, Jung SH. Epidemiologic characteristics of malignant mesothelioma in Korea. J Korean Med Assoc 2009;52:449-55. https://doi.org/10.5124/jkma.2009.52.5.449
- Carteni G, Manegold C, Garcia GM, Siena S, Zielinski CC, Amadori D, et al. Malignant peritoneal mesothelioma. Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent. Lung Cancer 2009;64:211-8. https://doi.org/10.1016/j.lungcan.2008.08.013
- Mirarabshahii P, Pillai K, Chua TC, Pourgholami MH, Morris DL. Diffuse malignant peritoneal mesothelioma: an update on treatment. Cancer Treat Rev 2012;38:605-12. https://doi.org/10.1016/j.ctrv.2011.10.006
- Chekol SS, Sun CC. Malignant mesothelioma of the tunica vaginalis testis: diagnostic studies and differential diagnosis. Arch Pathol Lab Med 2012;136:113-7. https://doi.org/10.5858/arpa.2010-0550-RS
- Sterman DH, Albelda SM. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma. Respirology 2005;10:266-83. https://doi.org/10.1111/j.1440-1843.2005.00714.x
- Gadgeel SM, Pass HI. Novel combinations using pemetrexed in malignant mesothelioma. Clin Lung Cancer 2004;5 Suppl 2:S61-6. https://doi.org/10.3816/CLC.2004.s.005
- Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 2010;35:479-95. https://doi.org/10.1183/09031936.00063109
- Kao SC, Yan TD, Lee K, Burn J, Henderson DW, Klebe S, et al. Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma. J Thorac Oncol 2011;6:602-5. https://doi.org/10.1097/JTO.0b013e31820ce2c7
- Greillier L, Cavailles A, Fraticelli A, Scherpereel A, Barlesi F, Tassi G, et al. Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma. Cancer 2007;110:2248-52. https://doi.org/10.1002/cncr.23034
- Hamamoto J, Notsute D, Tokunaga K, Sasaki J, Kojima K, Saeki S, et al. Diagnostic usefulness of endobronchial ultrasoundguided transbronchial needle aspiration in a case with malignant pleural mesothelioma. Intern Med 2010;49:423-6. https://doi.org/10.2169/internalmedicine.49.2825
- Kang B, Kim MA, Lee BY, Yoon H, Oh DK, Hwang HS, et al. Malignant pleural mesothelioma diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Tuberc Respir Dis 2013;74:74-8. https://doi.org/10.4046/trd.2013.74.2.74
- Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2013;137:647-67. https://doi.org/10.5858/arpa.2012-0214-OA
- DellaGiustina D, Falconieri G, Bonifacio-Gori D, Zanconati F, DiBonito L, Pizzolitto S. Bronchial cytology in pleural mesothelioma: a report of 3 positive cases, including 1 diagnosed initially on bronchial brushings. Acta Cytol 2003;47:1017-22. https://doi.org/10.1159/000326638